Rx Only (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 01)
Diflunisal Tablet
Product Images NDC 70771-1083
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diflunisal (NDC 70771-1083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structure (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 02)
Label (Aa36dffd E56d 43a9 Ab2e C2a6005c8b2b 03)
This is a description for Diflunisal Tablets USP which contains 100 tablets, each with 500 mg of diflunisal as the active ingredient. The medication guide should be provided separately to each patient by the pharmacist. The usual dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F) and in a well-closed container with a child-resistant closure. The drug must be kept tightly closed and out of the reach of children. This medication is manufactured by Cadila Healthcare Ltd. in Baddi, India.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
